亲爱的研友该休息了!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!身体可是革命的本钱,早点休息,好梦!

Repeat corneal transplantation in Southern China: Indications, surgical technique, outcomes, and risk factors for repeat keratoplasty failure

医学 外科 角膜移植 移植 眼科
作者
Qi Zheng,Qinxiang Zheng,Wuhe Chen,Jinyang Li,Zelin Zhao,Haiou Wang,Dan Jiang,Wei Chen
出处
期刊:Indian Journal of Ophthalmology [Medknow]
卷期号:72 (Suppl 3): S482-S487
标识
DOI:10.4103/ijo.ijo_3333_23
摘要

Purpose: To report the indications, surgical techniques, and outcomes of repeat keratoplasty and evaluate the risk factors for graft failure in the Chinese population. Methods: The medical records of 216 patients (243 cases) who underwent at least two keratoplasties at a leading eye hospital in southern China between 2011 and 2020 were retrospectively reviewed. Indications and surgical procedures for repeat corneal transplantation were analyzed. Kaplan–Meier survival analysis was used to determine the graft survival rate after repeat keratoplasty. A multivariable survival model was used to assess the risk factors. Results: Repeated keratoplasties increased continuously from 2011 to 2020 ( P = 0.002). The most common primary indication was infectious keratitis (38.7%), and the most common reason for repeat keratoplasty was graft rejection (30.04%). Regraft techniques included penetrating keratoplasty (PK) in 165 cases (67.9%), deep lamellar keratoplasty (DALK) in 52 cases (21.40%), and endothelial keratoplasty (EK) in 26 cases (10.7%). Median survival was 5.3, 6.8, and 6.4 years for PK, DALK, and EK, respectively. The 5-year survival rate was 53.5%, 66.6%, and 69.8% for PK, DALK, and EK, respectively. The median LogMAR visual acuity was 1.4 for PK, 0.75 for DALK, and 1.2 for EK at the end of the follow-up. Multivariate analysis revealed that graft rejection is a risk factor for repeat keratoplasty failure ( P = 0.002). Conclusions: DALK and EK may provide better outcomes than PK in treating graft failure. Preventing and treating postoperative graft rejection may be key to improving regraft survival. These findings will aid in the management of failed corneal grafts.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
1秒前
曹天德发布了新的文献求助10
6秒前
懒得起名字完成签到 ,获得积分10
7秒前
多情遥完成签到,获得积分10
11秒前
多情遥发布了新的文献求助10
15秒前
曹天德完成签到,获得积分10
17秒前
传奇3应助科研通管家采纳,获得10
25秒前
qiqi完成签到,获得积分20
1分钟前
陈晓迪1992完成签到,获得积分10
1分钟前
Huayan完成签到,获得积分20
1分钟前
Huayan发布了新的文献求助10
1分钟前
1分钟前
moyu123发布了新的文献求助10
2分钟前
qc发布了新的文献求助10
2分钟前
神勇大开完成签到,获得积分10
3分钟前
rrrrr发布了新的文献求助10
3分钟前
moyu123发布了新的文献求助10
3分钟前
moyu123完成签到,获得积分10
3分钟前
rrrrr完成签到,获得积分10
3分钟前
qc完成签到,获得积分10
3分钟前
Ava应助神勇大开采纳,获得10
3分钟前
张海桐发布了新的文献求助10
4分钟前
YifanWang完成签到,获得积分0
4分钟前
张海桐完成签到,获得积分20
4分钟前
yh完成签到,获得积分10
4分钟前
4分钟前
科研通AI2S应助科研通管家采纳,获得10
4分钟前
思源应助张海桐采纳,获得10
4分钟前
满意的伊完成签到,获得积分10
4分钟前
NEM嬛嬛驾到完成签到,获得积分10
5分钟前
5分钟前
子非鱼发布了新的文献求助10
5分钟前
乐柚完成签到,获得积分10
5分钟前
周周南完成签到 ,获得积分0
6分钟前
6分钟前
journey完成签到 ,获得积分10
6分钟前
威武的晋鹏完成签到,获得积分10
7分钟前
上官若男应助fei采纳,获得10
8分钟前
彭于晏应助al采纳,获得10
8分钟前
烟花应助科研通管家采纳,获得10
8分钟前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
PowerCascade: A Synthetic Dataset for Cascading Failure Analysis in Power Systems 2000
Various Faces of Animal Metaphor in English and Polish 800
Signals, Systems, and Signal Processing 610
Adverse weather effects on bus ridership 500
Photodetectors: From Ultraviolet to Infrared 500
On the Dragon Seas, a sailor's adventures in the far east 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 工程类 有机化学 化学工程 生物化学 计算机科学 物理 内科学 复合材料 催化作用 物理化学 光电子学 电极 细胞生物学 基因 无机化学
热门帖子
关注 科研通微信公众号,转发送积分 6350578
求助须知:如何正确求助?哪些是违规求助? 8165226
关于积分的说明 17181910
捐赠科研通 5406819
什么是DOI,文献DOI怎么找? 2862681
邀请新用户注册赠送积分活动 1840282
关于科研通互助平台的介绍 1689456